Clinical Trial Update: Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, and efficacy of V117957 for insomnia associated with alcohol cessation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• V117957

Snippet

Sponsor: Imbrium Therapeutics | Conditions: Insomnia | Phase 2 | Status: COMPLETED | Results posted: 2023-09-18